Recent News

• 03.13.2025 - aTyr Pharma Fourth Quarter and Full Year 2024 Financial Results Conference Call
• 03.13.2025 - aTyr Pharma Fourth Quarter and Full Year 2024 Financial Results Conference Call
• 03.10.2025 - Leerink Partners Global Healthcare Conference
• 03.10.2025 - Leerink Partners Global Healthcare Conference
• 03.10.2025 - Leerink Partners Global Healthcare Conference
• 03.10.2025 - Leerink Partners Global Healthcare Conference
• 03.06.2025 - aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
• 03.06.2025 - aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
• 03.06.2025 - aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
• 03.04.2025 - aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results

Recent Filings

• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities